BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 118 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $809,000 | -46.8% | 70,958 | -30.4% | 0.00% | 0.0% |
| Q2 2015 | $1,521,000 | +123.7% | 101,896 | +46.6% | 0.00% | +100.0% |
| Q3 2014 | $680,000 | -22.0% | 69,518 | 0.0% | 0.00% | -50.0% |
| Q2 2014 | $872,000 | +50.1% | 69,518 | -2.7% | 0.00% | +100.0% |
| Q1 2014 | $581,000 | -16.6% | 71,428 | -25.4% | 0.00% | 0.0% |
| Q3 2013 | $697,000 | +69600.0% | 95,795 | +27910.2% | 0.00% | – |
| Q2 2013 | $1,000 | – | 342 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management II, LLC | 6,071,142 | $50,998,000 | 20.86% |
| RTW INVESTMENTS, LP | 3,458,120 | $29,048,000 | 7.65% |
| ISZO CAPITAL MANAGEMENT LP | 307,366 | $2,582,000 | 4.49% |
| DAFNA Capital Management LLC | 541,128 | $4,545,000 | 3.84% |
| RA Capital Management | 3,489,795 | $29,314,000 | 3.60% |
| EMORY UNIVERSITY | 375,348 | $3,153,000 | 2.98% |
| Ghost Tree Capital, LLC | 1,500,000 | $12,600,000 | 2.35% |
| ACUTA CAPITAL PARTNERS, LLC | 920,310 | $7,731,000 | 1.83% |
| Avoro Capital Advisors LLC | 1,603,001 | $13,465,000 | 1.72% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,085,236 | $25,916,000 | 1.00% |